207 related articles for article (PubMed ID: 28282121)
21. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiester-mediated reaction of cisplatin with guanine in oligodeoxyribonucleotides.
Campbell MA; Miller PS
Biochemistry; 2008 Dec; 47(48):12931-8. PubMed ID: 18991396
[TBL] [Abstract][Full Text] [Related]
23. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
[TBL] [Abstract][Full Text] [Related]
24. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
[TBL] [Abstract][Full Text] [Related]
25. DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: a comparative study with cisplatin drug.
N'soukpoé-Kossi CN; Descôteaux C; Asselin E; Tajmir-Riahi HA; Bérubé G
DNA Cell Biol; 2008 Feb; 27(2):101-7. PubMed ID: 17970617
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
27. Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
Baskerville-Abraham IM; Boysen G; Troutman JM; Mutlu E; Collins L; Dekrafft KE; Lin W; King C; Chaney SG; Swenberg JA
Chem Res Toxicol; 2009 May; 22(5):905-12. PubMed ID: 19323581
[TBL] [Abstract][Full Text] [Related]
28. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
29. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
[TBL] [Abstract][Full Text] [Related]
30. Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines.
Haririan I; Alavidjeh MS; Khorramizadeh MR; Ardestani MS; Ghane ZZ; Namazi H
Int J Nanomedicine; 2010 Feb; 5():63-75. PubMed ID: 20161988
[TBL] [Abstract][Full Text] [Related]
31. HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene.
Goggin M; Loeber R; Park S; Walker V; Wickliffe J; Tretyakova N
Chem Res Toxicol; 2007 May; 20(5):839-47. PubMed ID: 17455958
[TBL] [Abstract][Full Text] [Related]
32. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
Chválová K; Brabec V; Kaspárková J
Nucleic Acids Res; 2007; 35(6):1812-21. PubMed ID: 17329374
[TBL] [Abstract][Full Text] [Related]
34. Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex.
Kaspárková J; Mackay FS; Brabec V; Sadler PJ
J Biol Inorg Chem; 2003 Sep; 8(7):741-5. PubMed ID: 14505077
[TBL] [Abstract][Full Text] [Related]
35. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
[TBL] [Abstract][Full Text] [Related]
36. Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis.
Hansson J; Lewensohn R; Ringborg U
Acta Oncol; 1988; 27(4):383-92. PubMed ID: 3202996
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR
Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660
[TBL] [Abstract][Full Text] [Related]
38. Novel insights into the bottom-up mass spectrometry proteomics approach for the characterization of Pt-binding proteins: The insulin-cisplatin case study.
Moreno-Gordaliza E; Cañas B; Palacios MA; Gómez-Gómez MM
Analyst; 2010 Jun; 135(6):1288-98. PubMed ID: 20411195
[TBL] [Abstract][Full Text] [Related]
39. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
40. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
